(August 04 18:30) Forbes.com
The stock price of Pfizer has seen an 11% rise over the last twenty-one trading days, and most of the gains have come over the last ten trading days, after the company reported strong Q2 results, and revised its full-year outlook upward. Note that such a move for PFE stock is uncommon, and it has...
You can find the original article
here